Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.

Merck (MRK) announced the opening of a new, $1B, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, site. This expansion of our Durham plant is a ...

The new 225,000-square-foot facility will enhance Merck's vaccine production capabilities and create new jobs.

(Reuters) -Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's ...

Executives mingled with North Carolina leaders in the city of Wilson to ceremonially break ground on Johnson & Johnson’s ...

An analysis by ING Bank suggests that proposed tariffs could increase the cost of certain cancer treatments by up to $10,000 ...

Merck plans to invest $8 billion more in U.S. by 2028. A global health care company is growing its footprint in North Carolina with a $1 billion investment. Merck (NYSE: MRK) has opened a new ...

The pharmaceutical ingredients manufacturer will conduct three rounds of job cuts starting in May and continuing through 2026 ...

Merck has been in north Durham since 2004 ... Each of these pharma companies has in recent years committed to expand in North Carolina as drug production boosts economic growth in the Triangle ...